MAY 13, 2020 3:44 PM PDT

Drug Targets Off Episodes of Parkinson

WRITTEN BY: Nouran Amin

A novel drug was approved by the FDA to target the “off” episodes of Parkinson disease. The drug is referred to as ‘Ongentys’ which is a catechol-o-methyltransferase (COMT) inhibitor that when combined with another drug improves treatment efficacy. In other words, Ongentys works with levodopa to increase more dopamine entry into the brain.

Learn more about Parkinson:

Dopamine is brain fuel that stimulates normal movements and decreases symptoms associated with Parkinson.

Learn more about dopamine:

Some adverse effects associated with Ongentys use includes abnormal dreams, headaches, sleep challenges, hallucinations, and low blood pressure. Although some complications, such as dyskinesia (involuntary movements), is related to levodopa boost rather than Ongentys alone.

Source: MichaelJFox.org

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
FEB 24, 2022
Cannabis Sciences
Study Reveals Cannabis and Tobacco Affect the Lungs Differently
FEB 24, 2022
Study Reveals Cannabis and Tobacco Affect the Lungs Differently
Scientists recently discovered differences in how long-term consumption of cannabis and tobacco affect the lungs. A stud ...
MAR 07, 2022
Cannabis Sciences
Cannabis compound CBN supports mitochondrial function
MAR 07, 2022
Cannabis compound CBN supports mitochondrial function
Cannabinol (CBN) has been established as a neuroprotective, but a recent study reveals just how CBN protects mitochondri ...
MAR 10, 2022
Drug Discovery & Development
Drug Equipped with Iron Sensor Halts Cancer Tumor Growth
MAR 10, 2022
Drug Equipped with Iron Sensor Halts Cancer Tumor Growth
A modified version of an FDA-approved drug can halt tumor growth driven by mutations in the RAS gene, which are notoriou ...
MAR 18, 2022
Drug Discovery & Development
In drug development studies, sleep is an important and overlooked vital sign
MAR 18, 2022
In drug development studies, sleep is an important and overlooked vital sign
Today is World Sleep Day, a celebration of sleep that aims to bring awareness to the importance of sleep as a found ...
MAR 28, 2022
Plants & Animals
An Alternative to Morphine Could Come From a Poisonous Snail
MAR 28, 2022
An Alternative to Morphine Could Come From a Poisonous Snail
Morphine is a synthetic narcotic designed to treat severe pain. As an opioid, tt is created from opium, or the seeds fro ...
APR 21, 2022
Drug Discovery & Development
Antidepressants and Anti-epileptics During Pregnancy May Affect Infant Brain Development
APR 21, 2022
Antidepressants and Anti-epileptics During Pregnancy May Affect Infant Brain Development
Fetal exposure to a mother's antiepileptic or antidepressant medication may affect infant brain development. The cor ...
Loading Comments...